11月 2025
- 首頁
- Encoded Therapeutics, Inc.
11月 2025Encoded Therapeutics, Inc.的市場佔有率分析
Encoded Therapeutics, Inc.(包含公司地區)
查看更多網站流量與參與度資訊- encoded.com
Encoded Therapeutics, Inc.截至 11月 2025 的總收入為 15M - 25M
Encoded Therapeutics, Inc. 熱門網域產生的總收入
Encoded Therapeutics, Inc. 熱門網域 3 年內的總收入
Encoded Therapeutics, Inc. 熱門網域的總收入
Encoded Therapeutics, Inc.的熱門網域總造訪量
了解Encoded Therapeutics, Inc.市場觸達率與潛在市場影響力。
過去 3 個月的訪問總量
子公司細目
Encoded Therapeutics, Inc.的熱門網域平均造訪時長
分析Encoded Therapeutics, Inc.參與度指標。
過去 3 個月平均造訪時長
子公司細目
Encoded Therapeutics, Inc.的熱門網域平均頁面瀏覽量
了解Encoded Therapeutics, Inc.如何保持使用者的參與度、培養其興趣,並鼓勵他們採取下一步。
過去 3 個月平均頁面瀏覽量
子公司細目
想要取得更深入的流量洞見?
篩選超過 2,030 萬家線上企業。在流量激增、開始或停止使用技術或獲得正面評價時,發現新的潛在客戶。
新聞與訊號來自Encoded Therapeutics, Inc.
透過 Similarweb 銷售訊號提醒,每當目標受眾出現新的機會或威脅時,你就會收到每日更新的已識別購買訊號。
新聞Encoded Genomics, Inc. attends event 17th Annual Global Science Summit.At the Foundation for Angelman Syndrome Therapeutics (FAST) 17th Annual Global Science Summit in Orlando, FL, Encoded will present data showing that ETX201 was well tolerated in non-human primates (NHPs) with broad expression across multiple brain regions following a single intracerebroventricular administration.
11月 7, 2024閱讀更多
新聞Encoded Genomics, Inc. launches initial findings from ENVISION natural history study of children living with SCN1A+ Dravet syndrome.South San Francisco, Calif. - Dec. 3, 2021 - Encoded Therapeutics today announced initial findings from its ENVISION natural history study of children living with SCN1A+ Dravet syndrome, a rare developmental and epileptic encephalopathy.
12月 2, 2021閱讀更多
新聞Encoded Genomics, Inc. launched DRAVET ENGAGE initiative on Jul 20th '20.A little over a year ago, Encoded launched its DRAVET ENGAGE initiative to capture the Dravet syndrome patient community’s experiences and perspectives and to solicit feedback on clinical study protocols and designs, as well as on educational materials.
7月 19, 2021閱讀更多
查看所有Encoded Therapeutics, Inc.信號
讓銷售團隊專注於最有希望的機會。透過安排機會的優先順序,並在正確的時間參與,您可將工作最佳化,並完成更多交易。